Diagnostica Stago Inc - Product Pipeline Analysis, 2019 Update
December 2019
36
About the Report
About the Report
Summary
Diagnostica Stago Inc (Stago), a subsidiary of Diagnostica Stago SAS, is a medical device company that develops and distributes in-vitro diagnostic products. It develops coagulation automation systems. It provides products such as hemostasis analyzers, viscosity based detection systems, reagents and research products. Stago's research and reagent products includes venoms, activators, purified proteins, coagulation factors, inhibitors, chromogenic substrates, lupus inhibitors, heparin anti-xa assays, coagulation inhibitors, fibrin and fibrinogen degradation products, among others. The company offers various customer services such as proficiency testing, field technical support, education and customer training. It also offers hemostasis proficiency testing program and peer group program. The company operates in the US and Canada. Stago is headquartered in Parsippany, New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Diagnostica Stago Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Diagnostica Stago Inc, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
Helena Laboratories Corp
BioMed Diagnostics Inc
Alfa Wassermann Diagnostic Technologies, LLC
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Diagnostica Stago Inc Company Overview
Diagnostica Stago Inc Company Snapshot
Diagnostica Stago Inc Pipeline Products and Ongoing Clinical Trials Overview
Diagnostica Stago Inc-Pipeline Analysis Overview
Diagnostica Stago Inc-Key Facts
Diagnostica Stago Inc-Major Products and Services
Diagnostica Stago Inc Pipeline Products by Development Stage
Diagnostica Stago Inc Pipeline Products Overview
Calibrated Automated Thrombogram-Thrombin Assay
Calibrated Automated Thrombogram-Thrombin Assay Product Overview
STA Compact Max-Apixaban Calibrators And Controls
STA Compact Max-Apixaban Calibrators And Controls Product Overview
STA Compact Max-Dabigatran Calibrator And Control
STA Compact Max-Dabigatran Calibrator And Control Product Overview
STA Compact Max-Edoxaban Calibrator And Control
STA Compact Max-Edoxaban Calibrator And Control Product Overview
STA Compact Max-NeoPTimal ISI
STA Compact Max-NeoPTimal ISI Product Overview
STA Compact Max-Ristocetin Cofactor Assay
STA Compact Max-Ristocetin Cofactor Assay Product Overview
STA Compact Max-Rivaroxaban Calibrators And Controls For Anti-Xa
STA Compact Max-Rivaroxaban Calibrators And Controls For Anti-Xa Product Overview
STA-R Evolution Expert-Automated Ecarin Chromogenic Assay
STA-R Evolution Expert-Automated Ecarin Chromogenic Assay Product Overview
STA-R Evolution Expert-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa
STA-R Evolution Expert-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa Product Overview
STA-R Evolution Plus-Automated Ecarin Chromogenic Assay
STA-R Evolution Plus-Automated Ecarin Chromogenic Assay Product Overview
STA-R Evolution Plus-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa
STA-R Evolution Plus-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa Product Overview
STA-R Max-Apixaban Calibrators And Controls
STA-R Max-Apixaban Calibrators And Controls Product Overview
STA-R Max-Dabigatran Calibrator And Control
STA-R Max-Dabigatran Calibrator And Control Product Overview
STA-R Max-Edoxaban Calibrator And Control
STA-R Max-Edoxaban Calibrator And Control Product Overview
STA-R Max-NeoPTimal ISI
STA-R Max-NeoPTimal ISI Product Overview
STA-R Max-Ristocetin Cofactor Assay
STA-R Max-Ristocetin Cofactor Assay Product Overview
STA-R Max-Rivaroxaban Calibrators And Controls For Anti-Xa
STA-R Max-Rivaroxaban Calibrators And Controls For Anti-Xa Product Overview
Diagnostica Stago Inc-Key Competitors
Diagnostica Stago Inc-Key Employees
Diagnostica Stago Inc-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Diagnostica Stago Inc, Recent Developments
Sep 16, 2014: Stago's D-Dimer test, 1st assay to meet the new CLSI H59-A standards for exclusion of PE
Aug 18, 2009: Diagnostica Stago Opens New Training Center
May 04, 2009: Instrumentation Laboratory Wins Patent Infringement And Unfair Competition Trial Against Diagnostica Stago Relating To Reagents For Hemostasis Diagnostics
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Diagnostica Stago Inc Pipeline Products by Equipment Type
Diagnostica Stago Inc Pipeline Products by Development Stage
List of Table
List of Tables
Diagnostica Stago Inc Pipeline Products and Ongoing Clinical Trials Overview
Diagnostica Stago Inc Pipeline Products by Equipment Type
Diagnostica Stago Inc Pipeline Products by Indication
Diagnostica Stago Inc, Key Facts
Diagnostica Stago Inc, Major Products and Services
Diagnostica Stago Inc Number of Pipeline Products by Development Stage
Diagnostica Stago Inc Pipeline Products Summary by Development Stage
Calibrated Automated Thrombogram-Thrombin Assay-Product Status
Calibrated Automated Thrombogram-Thrombin Assay-Product Description
STA Compact Max-Apixaban Calibrators And Controls-Product Status
STA Compact Max-Apixaban Calibrators And Controls-Product Description
STA Compact Max-Dabigatran Calibrator And Control-Product Status
STA Compact Max-Dabigatran Calibrator And Control-Product Description
STA Compact Max-Edoxaban Calibrator And Control-Product Status
STA Compact Max-Edoxaban Calibrator And Control-Product Description
STA Compact Max-NeoPTimal ISI-Product Status
STA Compact Max-NeoPTimal ISI-Product Description
STA Compact Max-Ristocetin Cofactor Assay-Product Status
STA Compact Max-Ristocetin Cofactor Assay-Product Description
STA Compact Max-Rivaroxaban Calibrators And Controls For Anti-Xa-Product Status
STA Compact Max-Rivaroxaban Calibrators And Controls For Anti-Xa-Product Description
STA-R Evolution Expert-Automated Ecarin Chromogenic Assay-Product Status
STA-R Evolution Expert-Automated Ecarin Chromogenic Assay-Product Description
STA-R Evolution Expert-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa-Product Status
STA-R Evolution Expert-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa-Product Description
STA-R Evolution Plus-Automated Ecarin Chromogenic Assay-Product Status
STA-R Evolution Plus-Automated Ecarin Chromogenic Assay-Product Description
STA-R Evolution Plus-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa-Product Status
STA-R Evolution Plus-Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa-Product Description
STA-R Max-Apixaban Calibrators And Controls-Product Status
STA-R Max-Apixaban Calibrators And Controls-Product Description
STA-R Max-Dabigatran Calibrator And Control-Product Status
STA-R Max-Dabigatran Calibrator And Control-Product Description
STA-R Max-Edoxaban Calibrator And Control-Product Status
STA-R Max-Edoxaban Calibrator And Control-Product Description
STA-R Max-NeoPTimal ISI-Product Status
STA-R Max-NeoPTimal ISI-Product Description
STA-R Max-Ristocetin Cofactor Assay-Product Status
STA-R Max-Ristocetin Cofactor Assay-Product Description
STA-R Max-Rivaroxaban Calibrators And Controls For Anti-Xa-Product Status
STA-R Max-Rivaroxaban Calibrators And Controls For Anti-Xa-Product Description
Diagnostica Stago Inc, Key Employees
Diagnostica Stago Inc, Other Locations
Glossary
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.